Aeva Technologies, Inc.
Business
Aeva Technologies, Inc. develops and commercial 4D LiDAR-on-chip perception technology based on proprietary FMCW sensing to measure range, reflectivity and instantaneous velocity for every pixel. It offers integrated silicon photonics LiDAR sensors and modules (including Aeries II, Atlas and Atlas Ultra), custom digital signal processing ASICs and 4D perception software for object detection, classification, tracking and vehicle state estimation. Its primary business segments target automotive, industrial automation, consumer device and security applications. Aeva markets and distributes its solutions to OEMs, Tier 1 suppliers, mobility players and industrial customers via strategic partnerships, development agreements and third-party manufacturers for integration into final products.
Summary from filing dated 2025-03-21
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 18 | 9 | 4 | 4 | 9 | |
| Cost of revenue | 19 | 13 | 10 | 8 | 6 | |
| Gross loss | −660,000 | −4 | −6 | −4 | 3 | |
| Research and development expenses | 85 | 103 | 103 | 110 | 75 | |
| General and administrative expenses | 35 | 33 | 32 | 31 | 28 | |
| Selling and marketing expenses | 7 | 7 | 8 | 7 | 4 | |
| Litigation settlement, net | 0 | 12 | 0 | 0 | — | |
| Total operating expenses | 127 | 155 | 142 | 148 | 108 | |
| Operating loss | −128 | −158 | −148 | −152 | −104 | |
| Interest income | 3 | 8 | 9 | 4 | 372,000 | |
| Fair value at issuance of Series A warrants | 0 | 0 | −7 | — | — | |
| Change in fair value of warrant liabilities | −21 | −1 | −182,000 | — | — | |
| Fair value gain on settlement of share subscription liability | 2 | 0 | 0 | — | — | |
| Other income (expense), net | −459,000 | 56,000 | −4 | 943,000 | 2 | |
| Net loss before income taxes | −145 | −152 | −149 | −147 | −102 | |
| Income tax provision | 308,000 | 171,000 | 0 | 0 | 0 | |
| Net loss | −145 | −152 | −149 | −147 | −102 | |
| Unrealized (loss) gain on available-for-sale securities | −51,000 | 134,000 | 3 | −3 | −524,000 | |
| Total comprehensive loss | −145 | −152 | −146 | −150 | −102 | |
| Net loss per share, basic | −2.55 | −2.85 | −3.29 | −3.39 | −0.51 | |
| Net loss per share, diluted | −2.55 | −2.85 | −3.29 | −3.39 | −0.51 | |
| Weighted-average shares used in computing net loss per share, basic | 57 | 53 | 45 | 43 | 201 | |
| Weighted-average shares used in computing net loss per share, diluted | 57 | 53 | 45 | 43 | 201 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalent | 72 | 29 | 39 | 67 | 67 | |
| Marketable securities | 50 | 83 | 182 | 256 | 378 | |
| Accounts receivable, net | 3 | 1 | 628,000 | 3 | 2 | |
| Inventories | 6 | 2 | 2 | 3 | 2 | |
| Other current assets | 22 | 8 | 5 | 5 | 9 | |
| Total current assets | 154 | 123 | 229 | 335 | 458 | |
| Operating lease right-of-use assets | 5 | 4 | 7 | 7 | 10 | |
| Property, plant, and equipment, net | 13 | 10 | 12 | 10 | 5 | |
| Intangible assets, net | 825,000 | 2 | 3 | 4 | 4 | |
| Other noncurrent assets | 7 | 8 | 6 | 862,000 | 859,000 | |
| Total assets | 180 | 147 | 257 | 357 | 479 | |
| Accounts payable | 6 | 5 | 4 | 5 | 4 | |
| Accrued liabilities | 12 | 6 | 3 | 9 | 4 | |
| Accrued employee costs | 14 | 6 | 6 | 5 | 2 | |
| Lease liability, current portion | 1 | 3 | 4 | 3 | 3 | |
| Other current liabilities | 2 | 19 | 3 | 194,000 | 733,000 | |
| Total current liabilities | 36 | 39 | 18 | 22 | 14 | |
| Lease liability, noncurrent portion | 4 | 720,000 | 4 | 5 | 7 | |
| Convertible notes | 97 | 0 | — | — | — | |
| Warrant liability | 30 | 8 | 7 | 90,000 | 1 | |
| Total liabilities | 166 | 48 | 29 | 27 | 23 | |
| Commitments and contingencies (Note 15) | — | — | — | — | — | |
| Convertible preferred stock $0.0001 par value, 10,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 0 | 0 | 0 | 0 | 0 | |
| Common stock $0.0001 par value; 422,000 shares authorized; 61,580 and 54,140 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 6,000 | 6,000 | 5,000 | 22,000 | 21,000 | |
| Additional paid-in capital | 771 | 711 | 688 | 644 | 620 | |
| Accumulated other comprehensive (loss) income | −4,000 | 47,000 | −87,000 | −4 | −524,000 | |
| Accumulated deficit | −757 | −612 | −460 | −310 | −163 | |
| Total stockholders' equity | 13 | 99 | 228 | 330 | 456 | |
| Total liabilities and stockholders' equity | 180 | 147 | 257 | 357 | 479 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −145 | −152 | −149 | −147 | −102 | |
| Depreciation and amortization | 5 | 5 | 5 | 3 | 1 | |
| Impairment of inventories | 493,000 | 1 | 224,000 | 2 | 0 | |
| Loss on joint development agreement (2) | 4 | 0 | 0 | — | — | |
| Stock-based compensation | 22 | 24 | 24 | 24 | 22 | |
| Amortization of right-of-use assets | 3 | 3 | 3 | 3 | 2 | |
| Amortization of premium and accretion of discount on available-for-sale securities, net | −1 | −4 | −3 | 389,000 | 1 | |
| Other | 423,000 | 563,000 | 0 | 0 | — | |
| Accounts receivable, net | −3 | −559,000 | 2 | −546,000 | −2 | |
| Inventories | −4 | −1 | 353,000 | −3 | −844,000 | |
| Other current assets | −9 | −3 | 279,000 | 4 | −7 | |
| Other noncurrent assets | 288,000 | 318,000 | −270,000 | −3,000 | −795,000 | |
| Accounts payable | −504,000 | 2 | −2 | 1 | 3 | |
| Accrued liabilities | 3 | 2 | −6 | 5 | 3 | |
| Accrued employee costs | 8 | −260,000 | 1 | 3 | — | |
| Lease liability | −3 | −4 | −3 | −3 | −2 | |
| Other current liabilities | −18 | 17 | 2 | −539,000 | 458,000 | |
| Net cash used in operating activities | −115 | −107 | −119 | −110 | −82 | |
| Purchase of property, plant, and equipment (including advance) | −5 | −5 | −6 | −7 | −4 | |
| Purchase of non-marketable equity investments | 0 | 0 | −5 | 0 | 0 | |
| Purchase of available-for-sale securities | −75 | −80 | −152 | −210 | −572 | |
| Proceeds from maturities of available-for-sale securities | 110 | 183 | 233 | 329 | 172 | |
| Net cash provided by investing activities | 30 | 98 | 69 | 111 | −389 | |
| Proceeds from issuance of stock in private placement | 33 | 0 | 21 | 0 | 0 | |
| Transaction costs related to business combination and private offering | −400,000 | — | 0 | 0 | −47 | |
| Transaction costs related to issuance of stock in private placement | — | 0 | −818,000 | 0 | 0 | |
| Proceeds from convertible notes | 100 | 0 | 0 | — | — | |
| Transaction costs related to convertible notes | −3 | 0 | 0 | — | — | |
| Payments of taxes withheld on net settled vesting of restricted stock units | −578,000 | −752,000 | −199,000 | −720,000 | −1 | |
| Proceeds from exercise of stock options | 128,000 | 81,000 | 238,000 | 350,000 | 911,000 | |
| Net cash (used in) provided by financing activities | 129 | −671,000 | 21 | −369,000 | 513 | |
| Net increase (decrease) in cash and cash equivalents | 43 | −10 | −29 | 610,000 | 42 | |
| Cash paid for interest | 0 | 0 | 0 | 0 | 0 | |
| Cash paid for income taxes | 174,000 | 165,000 | 0 | 0 | 0 | |
| Unpaid property, plant and equipment purchases | 727,000 | 835,000 | 90,000 | 79,000 | 796,000 | |
| Joint development contract assets | 8 | 0 | 0 | — | — | |
| Convertible debt issuance cost included in accounts payable | 297,000 | 0 | 0 | — | — | |
| Right-of-use asset obtained in exchange for lease liability | 5 | 0 | 3 | 0 | 11 |